Effects of testosterone and levonorgestrel combined with a 5α-reductase inhibitor or gonadotropin-releasing hormone antagonist on spermatogenesis and intratesticular steroid levels in normal men

被引:46
作者
Matthiesson, KL
Stanton, PG
O'Donnell, L
Meachem, SJ
Amory, JK
Berger, R
Bremner, WJ
McLachlan, RI
机构
[1] Monash Univ, Prince Henrys Inst Med Res, Monash Med Ctr, Clayton, Vic 3168, Australia
[2] Monash Univ, Dept Obstet & Gynecol, Monash Med Ctr, Clayton, Vic 3168, Australia
[3] Univ Washington, Ctr Res Reprod & Contracept, Seattle, WA 98195 USA
关键词
D O I
10.1210/jc.2005-0639
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Combination of a GnRH antagonist (cyline), types I and II, 5 alpha-reductase inhibitor (dutasteride) or levonorgestrel (LNG) with testosterone (T) treatment may augment the suppression of spermatogenesis and intratesticular (iT) steroids. Objective: The objective of this study was to assess the effects of combined hormonal contraceptive regimens on germ cell populations and iT steroids. Design, Setting, and Participants: Twenty-nine normal health men enrolled in this prospective, randomized, 14-wk study at the University of Washington. Intervention(s): Twenty-two men (n = 5-6/group) received 8 wk of T enanthate (TE; 100 mg, im, weekly) combined with 1) 125 mu g LNG daily, orally; 2) 125 mu g LNG plus 0.5 mg dutasteride daily, orally; 3) 300 mu g/kg acyline twice weekly, sc; or 4) 125 mu g LNG daily, orally, plus 300 mu g/kg acyline twice weekly, sc. Subjects then underwent a vasectomy and testicular biopsy. Control men (n = 7) proceeded directly to surgery. Main Outcome Measure(s): The main outcome measures were germ cells and iT steroids [T, dihydrotestosterone, 3 alpha- and beta-androstanediol (Adiol), and estradiol (E2)]. Results: High iT levels of all androgens (6- to 123-fold serum levels) and E2 (407-fold serum levels) were found in control men. iTT (1.9-2.6% control; P < 0.001) and iT3 beta Adiol (16-34% control; P < 0.05) levels decreased with all treatments. iT dihydrotestosterone (13-29% control; P < 0.05) and iT3 beta Adiol (44-47% control; P < 0.05) levels decreased with all but the TE plus LNG treatment. iTE2 levels decreased only in the TE plus acyline group (28% control; P = 0.01). Germ cells from type B spermatogonia onward were suppressed, with no differences between groups found. Variable sites of impairment of germ cell progression were evident between men (spermagonial maturation, meiosis 1 entry, and spermiation). Other than a negative correlation between iT3 beta Adiol and haploid germ cell number (P < 0.006), no correlations between germ cell number and gonadotropins, sperm concentration, or iT steroids were found. Conclusions: A similar high testicular: serum gradient exists for E2 and T in normal men, and 8 wk of gonadotropin suppression markedly reduces iTT, with 5 alpha-reduced androgens and E2 levels decreasing to a much lesser degree. The heterogeneity of the germ cell response, regardless of treatment, gonadotropins or iT steroids, points to the individual sensitivity of sites in germ cell development, which is worthy of additional exploration.
引用
收藏
页码:5647 / 5655
页数:9
相关论文
共 58 条
[1]   Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression [J].
Anawalt, BD ;
Herbst, KL ;
Matsumoto, AM ;
Mulders, TMT ;
Coelingh-Bennink, HJT ;
Bremner, WJ .
FERTILITY AND STERILITY, 2000, 74 (04) :707-714
[2]  
Anawalt BD, 1999, J ANDROL, V20, P407
[3]  
Anderson RA, 1997, J ANDROL, V18, P366
[4]   Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study .3. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterones [J].
Anderson, RA ;
Wallace, AM ;
Wu, FCW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) :902-908
[5]   Suppression of spermatogenesis by etonogestrel implants with depot testosterone: Potential for long-acting male contraception [J].
Anderson, RA ;
Kinniburgh, D ;
Baird, DT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) :3640-3649
[6]  
[Anonymous], 1990, Lancet, V336, P955
[7]  
Aribarg A, 1996, FERTIL STERIL, V65, P821
[8]   EFFECTIVE SUPPRESSION OF LUTEINIZING-HORMONE AND TESTOSTERONE BY SINGLE DOSES OF THE NEW GONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETRORELIX (SB-75) IN NORMAL MEN [J].
BEHRE, HM ;
KLEIN, B ;
STEINMEYER, E ;
MCGREGOR, GP ;
VOIGT, K ;
NIESCHLAG, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (02) :393-398
[9]   Regulation of aromatase gene expression in Leydig cells and germ cells [J].
Bourguiba, S ;
Genissel, C ;
Lambard, S ;
Bouraïma, H ;
Carreau, S .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 86 (3-5) :335-343
[10]   Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5α-reductase inhibitor [J].
Clark, RV ;
Hermann, DJ ;
Cunningham, GR ;
Wilson, TH ;
Morrill, BB ;
Hobbs, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05) :2179-2184